Skip to main content
TipRanks
Go Ultimate75% OFF

Joaquim Trias Insider Profile

4 Followers

Joaquim Trias, Sr. VP, Preclinical Developmen at Anthera Pharmaceuticals, holds 52.57K shares in Tetraphase (Ticker: TTPH), holds 198.55K shares in Anthera Pharmaceuticals (Ticker: ANTH).

Joaquim Trias's Trading History

TTPH
Tetraphase
Mar 27, 2013―Uninformative Buy―$119.86K
ANTH
Anthera Pharmaceuticals
Sep 23, 2010Sr. VP, Preclinical DevelopmenInformative Buy6.61K―

You May Also Like

Joaquim Trias insider profile FAQ

What is the percentage of profitable transactions made by Joaquim Trias?
The percentage of profitable transactions made by Joaquim Trias is 100%.
What is the average return per transaction made by Joaquim Trias?
The average return per transaction made by Joaquim Trias is 47.90%.
What stocks does Joaquim Trias hold?
Joaquim Trias holds: ANTH, TTPH stocks.
What was Joaquim Trias's most profitable transaction?
Joaquim Trias’s most profitable transaction was an Informative Buy of TTPH stock on March 19, 2013. The return on the trade was 78.50%.
What is Joaquim Trias's role in Anthera Pharmaceuticals?
Joaquim Trias's role in Anthera Pharmaceuticals is Sr. VP, Preclinical Developmen.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.